Mesolimbic dopamine and habenulo- interpeduncular pathways in nicotine withdrawal

Cold Spring Harbor Perspectives in Medicine

Volumn 3, Issue 6, 2013, Pages

  Dani, John A ^a   De Biasi, Mariella ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR;

ANIMAL; ANIMAL BEHAVIOR; ARTICLE; DRUG EFFECT; HABENULA; HUMAN; LIMBIC SYSTEM; METABOLISM; PSYCHOLOGICAL ASPECT; REINFORCEMENT; SIGNAL TRANSDUCTION; WITHDRAWAL SYNDROME;

ANIMALS; BEHAVIOR, ANIMAL; DOPAMINE; HABENULA; HUMANS; LIMBIC SYSTEM; NICOTINE; NICOTINIC AGONISTS; RECEPTORS, NICOTINIC; REINFORCEMENT (PSYCHOLOGY); SIGNAL TRANSDUCTION; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84878984984     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a012138     Document Type: Article

References (136)

1. al'Absi M, Hatsukami D, Davis GL, Wittmers LE. 2004. Prospective examination of effects of smoking abstinence on cortisol and withdrawal symptoms as predictors of early smoking relapse. Drug Alcohol Depend 73: 267-278.
2. Allen S.S., Bade T, Hatsukami D, Center B. 2008. Craving, withdrawal, and smoking urges on days immediately prior to smoking relapse. Nicotine Tob Res 10: 35-45.
3. American Psychiatric Association. 2000. Diagnostic and statistical manual-text revision (DSM-IV-TR). American Psychiatric Association, Washington, DC.
4. Amos C.I., Wu X, Broderick P, Gorlov IP, Gu J, Eisen T, Dong Q., Zhang Q, Gu X, Vijayakrishnan J, et al. 2008. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 40: 616-622.
5. Araki M., McGeer PL, Kimura H. 1988. The efferent projections of the rat lateral habenular nucleus revealed by the PHA-L anterograde tracing method. Brain Res 441: 319-330.
6. Balcita-Pedicino JJ, Omelchenko N, Bell R, Sesack SR. 2011. The inhibitory influence of the lateral habenula on midbrain dopamine cells: Ultrastructural evidence for indirect mediation via the rostromedial mesopontine tegmental nucleus. J Comp Neurol 519: 1143-1164.
7. Benowitz NL. 2008. Clinical pharmacology of nicotine: Implications for understanding, preventing, and treating tobacco addiction. Clin Pharmacol Ther 83: 531-541.
8. Benowitz NL. 2010. Nicotine addiction. N Engl J Med 362: 2295-2303.
9. Benowitz N.L., Jacob P 3rd. 2001. Trans-30-hydroxycotinine: disposition kinetics, effects and plasma levels during cigarette smoking. Br J Clin Pharmacol 51: 53-59.
10. BerrettiniW, Yuan X, Tozzi F, Song K, Francks C, Chilcoat H, Waterworth D., Muglia P, Mooser V. 2008. α5/α3 nicotinic receptor subunit alleles increase risk for heavy smoking. Mol Psychiatry 13: 368-373.
11. Besson M., David V, Suarez S, Cormier A, Cazala P, Changeux J.P., Granon S. 2006. Genetic dissociation of two behaviors associated with nicotine addiction: β2 containing nicotinic receptors are involved in nicotine reinforcement but not in withdrawal syndrome. Psychopharmacology (Berl) 187: 189-199.
12. Bierut L.J., Stitzel JA, Wang JC, Hinrichs AL, Grucza RA, Xuei X., Saccone NL, Saccone SF, Bertelsen S, Fox L, et al. 2008. Variants in nicotinic receptors and risk for nicotine dependence. Am J Psychiatry 165: 1163-1171.
13. Björklund A, Lindvall O. 1984. Dopamine-containing systems in the CNS. In Classical transmitters in the CNS, Part I (ed. Björklund A, Hökfelt T), pp. 55-122. Elsevier, Amsterdam.
14. Brischoux F., Chakraborty S, Brierley DI, Ungless MA. 2009. Phasic excitation of dopamine neurons in ventral VTA by noxious stimuli. Proc Natl Acad Sci 106: 4894-4899.
15. Brunzell D.H., Boschen KE, Hendrick ES, Beardsley PM, McIntosh JM. 2010. α-conotoxin MII-sensitive nicotinic acetylcholine receptors in the nucleus accumbens shell regulate progressive ratio responding maintained by nicotine. Neuropsychopharmacology 35: 665-673.
16. Chen J., Wu X, Pande M, Amos CI, Killary AM, Sen S, Frazier ML. 2011. Susceptibility locus for lung cancer at 15q25.1 is not associated with risk of pancreatic cancer. Pancreas 40: 872-875.
17. CorrigallWA, Coen KM, Adamson KL. 1994. Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res 653: 278-284.
18. Cragg SJ. 2003. Variable dopamine release probability and short-term plasticity between functional domains of the primate striatum. J Neurosci 23: 4378-4385.
19. Cragg S.J., Hille CJ, Greenfield SA. 2002. Functional domains in dorsal striatum of the nonhuman primate are defined by the dynamic behavior of dopamine. J Neurosci 22: 5705-5712.
20. Dani J.A., Harris RA. 2005. Nicotine addiction and comorbiditywith alcohol abuse and mental illness. NatNeurosci 8: 1465-1470.
21. Dani J.A., Heinemann S. 1996. Molecular and cellular aspects of nicotine abuse. Neuron 16: 905-908.
22. Dani J.A., Radcliffe KA, Pidoplichko VI. 2000. Variations in desensitization of nicotinic acetylcholine receptors from hippocampus and midbrain dopamine areas. Eur J Pharmacol 393: 31-38.
23. Dani J.A., Kosten TR, Benowitz NL. 2009. The pharmacology of nicotine and tobacco. In Principles of addiction medicine (ed. Ries RK, et al.), pp. 179-191. Lippincott Williams & Wilkins, Philadelphia.
24. De Biasi M, Dani JA. 2011. Reward, addiction, withdrawal to nicotine. Annu Rev Neurosci 34: 105-130.
25. De Biasi M, Salas R. 2008. Influence of neuronal nicotinic receptors over nicotine addiction and withdrawal. Exp Biol Med (Maywood) 233: 917-929.
26. Di Chiara G. 1999. Drug addiction as dopamine-dependent associative learning disorder. Eur J Pharmacol 375: 13-30.
27. Doll R., Peto R, Boreham J, Sutherland I. 2004. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 328: 1519.
28. Drenan R.M., Grady SR, Steele AD, McKinney S, Patzlaff NE, McIntosh JM, Marks MJ, Miwa JM, Lester HA. 2010. Cholinergic modulation of locomotion and striatal dopamine release is mediated by α6α4* nicotinic acetylcholine receptors. J Neurosci 30: 9877-9889.
29. Epping-Jordan MP, Watkins SS, Koob GF, Markou A. 1998. Dramatic decreases in brain reward function during nicotine withdrawal. Nature 393: 76-79.
30. Exley R., Clements MA, Hartung H, McIntosh JM, Cragg SJ. 2008. α6-containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens. Neuropsychopharmacology 33: 2158-2166.
31. Exley R., Maubourguet N, David V, Eddine R, Evrard A, Pons S., Marti F, Threlfell S, Cazala P, McIntosh JM, Changeux J.P., Maskos U, Cragg SJ, Faure P. 2011. Distinct contributions of nicotinic acetylcholine receptor subunit fαg4 and subunit fαg6 to the reinforcing effects of nicotine. Proc Natl Acad Sci 108: 7577-7582.
32. Fowler C.D., Lu Q, Johnson PM, Marks MJ, Kenny PJ. 2011. Habenular α5 nicotinic receptor subunit signalling controls nicotine intake. Nature 471: 597-601.
33. Gangitano D., Salas R, Teng Y, Perez E, De Biasi M. 2009. Progesterone modulation of α5 nAChR subunits influences anxiety-related behavior during estrus cycle. Genes Brain Behav 8: 398-406.
34. Garris P.A., Wightman RM. 1994. Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: An in vivo voltammetric study. J Neurosci 14: 442-450.
35. Geisler S., Trimble M. 2008. The lateral habenula: No longer neglected. CNS Spectr 13: 484-489.
36. Geisler S., Zahm DS. 2005. Afferents of the ventral tegmental area in the rat-anatomical substratum for integrative functions. J Comp Neurol 490: 270-294.
37. Geisler S., Derst C, Veh RW, Zahm DS. 2007. Glutamatergic afferents of the ventral tegmental area in the rat. JNeurosci 27: 5730-5743.
38. Geisler S., Marinelli M, Degarmo B, Becker ML, Freiman AJ, Beales M., Meredith GE, Zahm DS. 2008. Prominent activation of brainstem and pallidal afferents of the ventral tegmental area by cocaine. Neuropsychopharmacology 33: 2688-2700.
39. Gilbert D.G., McClernon FJ, Rabinovich NE, Dibb WD, Plath L.C., Hiyane S, Jensen RA, Meliska CJ, Estes SL, Gehlbach BA. 1999. EEG, physiology, and task-related mood fail to resolve across 31 days of smoking abstinence: Relations to depressive traits, nicotine exposure, and dependence. Exp Clin Psychopharmacol 7: 427-443.
40. Gilbert D.G., McClernon FJ, Rabinovich NE, Plath LC, Masson C.L., Anderson AE, Sly KF. 2002. Mood disturbance fails to resolve across 31 days of cigarette abstinence in women. J Consult Clin Psychol 70: 142-152.
41. Grace A.A., Bunney BS. 1979. Paradoxical GABAexcitation of nigral dopaminergic cells: indirect mediation through reticulata inhibitory neurons. Eur J Pharmacol 59: 211-218.
42. Grady S.R., Moretti M, Zoli M, Marks MJ, Zanardi A, Pucci L, Clementi F., Gotti C. 2009. Rodent habenulo-interpeduncular pathway expresses a large variety of uncommon nAChR subtypes, but only the α3β4* and α3β3β4* subtypes mediate acetylcholine release. J Neurosci 29: 2272-2282.
43. Grenhoff J., Aston-Jones G, Svensson TH. 1986. Nicotinic effects on the firing pattern of midbrain dopamine neurons. Acta Physiol Scand 128: 351-358.
44. Groenewegen H.J., Ahlenius S, Haber SN, Kowall NW, Nauta WJ. 1986. Cytoarchitecture, fiber connections, and some histochemical aspects of the interpeduncular nucleus in the rat. J Comp Neurol 249: 65-102.
45. Herkenham M., Nauta WJ. 1979. Efferent connections of the habenular nuclei in the rat. J Comp Neurol 187: 19-47.
46. Hikosaka O., Bromberg-Martin E, Hong S, Matsumoto M. 2008. New insights on the subcortical representation of reward. Curr Opin Neurobiol 18: 203-208.
47. Hong S., Jhou TC, Smith M, Saleem KS, Hikosaka O. 2011. Negative reward signals from the lateral habenula to dopamine neurons are mediated by rostromedial tegmental nucleus in primates. J Neurosci 31: 11457-11471.
48. Hughes JR. 2007. Effects of abstinence from tobacco: Valid symptoms and time course. Nicotine Tob Res 9: 315-327.
49. Hughes J.R., Gust SW, Skoog K, Keenan RM, Fenwick JW. 1991. Symptoms of tobacco withdrawal. A replication and extension. Arch Gen Psychiatry 48: 52-59.
50. Hutchison M.A., Riley AL. 2008. Adolescent exposure to nicotine alters the aversive effects of cocaine in adult rats. Neurotoxicol Teratol 30: 404-411.
51. Hyman S.E., Malenka RC, Nestler EJ. 2006. Neural mechanisms of addiction: The role of reward-related learning and memory. Annu Rev Neurosci 29: 565-598.
52. Ikemoto S. 2010. Brain reward circuitry beyond the mesolimbic dopamine system: A neurobiological theory. Neurosci Biobehav Rev 35: 129-150.
53. Jhou T.C., Fields HL, Baxter MG, Saper CB, Holland PC. 2009a. The rostromedial tegmental nucleus (RMTg), a GABAergic afferent to midbrain dopamine neurons, encodes aversive stimuli and inhibits motor responses. Neuron 61: 786-800.
54. Jhou T.C., Geisler S, Marinelli M, Degarmo BA, Zahm DS. 2009b. The mesopontine rostromedial tegmental nucleus: A structure targeted by the lateral habenula that projects to the ventral tegmental area of Tsai and substantia nigra compacta. J Comp Neurol 513: 566-596.
55. Ji H., Shepard PD. 2007. Lateral habenula stimulation inhibits rat midbrain dopamine neurons through a GABAA receptor-mediated mechanism. J Neurosci 27: 6923-6930.
56. Kaufling J., Veinante P, Pawlowski SA, Freund-Mercier MJ, Barrot M. 2009. Afferents to the GABAergic tail of the ventral tegmental area in the rat. J Comp Neurol 513: 597-621.
57. Kenford S.L., Fiore MC. 2004. Promoting tobacco cessation and relapse prevention. Med Clin North Am 88: 1553-1574, xi-xii.
58. Kim U., Chang SY. 2005. Dendritic morphology, local circuitry, and intrinsic electrophysiology of neurons in the rat medial and lateral habenular nuclei of the epithalamus. J Comp Neurol 483: 236-250.
59. Klemm WR. 2004. Habenular and interpeduncularis nuclei: Shared components in multiple-function networks. Med Sci Monit 10: RA261-RA273.
60. Koob G.F., Le Moal M. 2001. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24: 97-129.
61. Koob G.F., Le Moal M. 2005. Plasticity of reward neurocircuitry and the "dark side" of drug addiction. NatNeurosci 8: 1442-1444.
62. Koob G.F., Volkow ND. 2010. Neurocircuitry of addiction. Neuropsychopharmacology 35: 217-238.
63. Kumari V., Postma P. 2005. Nicotine use in schizophrenia: The self medication hypotheses. Neurosci Biobehav Rev 29: 1021-1034.
64. Kuryatov A., Berrettini W, Lindstrom J. 2011. Acetylcholine receptor (AChR) α5 subunit variant associated with risk for nicotine dependence and lung cancer reduces (α4β2) α5 AChR function. Mol Pharmacol 79: 119-125.
65. Lecca S., Melis M, Luchicchi A, Ennas MG, Castelli MP, Muntoni A.L., Pistis M. 2011. Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cells. Neuropsychopharmacology 36: 589-602.
66. Mameli-Engvall M, Evrard A, Pons S, Maskos U, Svensson T.H., Changeux JP, Faure P. 2006. Hierarchical control of dopamine neuron-firing patterns by nicotinic receptors. Neuron 50: 911-921.
67. Mansvelder H.D., McGehee DS. 2000. Long-term potentiation of excitatory inputs to brain reward areas by nicotine. Neuron 27: 349-357.
68. Mansvelder H.D., McGehee DS. 2002. Cellular and synaptic mechanisms of nicotine addiction. J Neurobiol 53: 606-617.
69. Mansvelder H.D., Keath JR, McGehee DS. 2002. Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron 33: 905-919.
70. Marti F., Arib O, Morel C, Dufresne V, Maskos U, Corringer P.J., de Beaurepaire R, Faure P. 2011. Smoke extracts and nicotine, but not tobacco extracts, potentiate firing and burst activity of ventral tegmental area dopaminergic neurons in mice. Neuropsychopharmacology 36: 2244-2257.
71. Maskos U., Molles BE, Pons S, Besson M, Guiard BP, Guilloux J.P., Evrard A, Cazala P, Cormier A, Mameli-Engvall M., et al. 2005. Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature 436: 103-107.
72. MathersCD, LoncarD. 2006. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3: e442.
73. Matsumoto M., Hikosaka O. 2007. Lateral habenula as a source of negative reward signals in dopamine neurons. Nature 447: 1111-1115.
74. Matsumoto M., Hikosaka O. 2009. Representation of negative motivational value in the primate lateral habenula. Nature neuroscience 12: 77-84.
75. MMWR. 2005. State-specific prevalence of cigarette smoking and quitting among adults-United States. MMWR 54: 1124-1127.
76. Montague P.R., McClure SM, Baldwin PR, Phillips PE, Budygin E.A., Stuber GD, Kilpatrick MR, Wightman RM. 2004. Dynamic gain control of dopamine delivery in freely moving animals. J Neurosci 24: 1754-1759.
77. Montone K.T., Fass B, Hamill GS. 1988. Serotonergic and nonserotonergic projections from the rat interpeduncular nucleus to the septum, hippocampal formation and raphe: A combined immunocytochemical and fluorescent retrograde labelling study of neurons in the apical subnucleus. Brain Res Bull 20: 233-240.
78. Nauta W.J., Smith GP, Faull RL, Domesick VB. 1978. Efferent connections and nigral afferents of the nucleus accumbens septi in the rat. Neuroscience 3: 385-401.
79. Olson V.G., Nestler EJ. 2007. Topographical organization of GABAergic neurons within the ventral tegmental area of the rat. Synapse 61: 87-95.
80. Omelchenko N., Sesack SR. 2010. Periaqueductal gray afferents synapse onto dopamine and GABA neurons in the rat ventral tegmental area. J Neurosci Res 88: 981-991.
81. Parent A., Sato F, Wu Y, Gauthier J, Levesque M, Parent M. 2000. Organization of the basal ganglia: The importance of axonal collateralization. Trends Neurosci 23: S20-27.
82. Perrotti L.I., Bolanos CA, Choi KH, Russo SJ, Edwards S, Ulery P.G., Wallace DL, Self DW, Nestler EJ, Barrot M. 2005. dFosB accumulates in a GABAergic cell population in the posterior tail of the ventral tegmental area after psychostimulant treatment. Eur J Neurosci 21: 2817-2824.
83. Peto R., Lopez AD, Boreham J, Thun M, Heath C Jr, Doll R. 1996. Mortality from smoking worldwide. Br Med Bull 52: 12-21.
84. Phillipson OT. 1979. Afferent projections to the ventral tegmental area of Tsai and interfascicular nucleus: A horseradish peroxidase study in the rat. J Comp Neurol 187: 117-143.
85. Piasecki T.M., Jorenby DE, Smith SS, Fiore MC, Baker TB. 2003a. Smoking withdrawal dynamics: I. Abstinence distress in lapsers and abstainers. J Abnorm Psychol 112: 3-13.
86. Piasecki T.M., Jorenby DE, Smith SS, Fiore MC, Baker TB. 2003b. Smoking withdrawal dynamics: II. Improved tests of withdrawal-relapse relations. J Abnorm Psychol 112: 14-27.
87. Piasecki T.M., Jorenby DE, Smith SS, Fiore MC, Baker TB. 2003c. Smoking withdrawal dynamics: III. Correlates of withdrawal heterogeneity. Exp Clin Psychopharmacol 11: 276-285.
88. Picciotto MR. 2003. Nicotine as a modulator of behavior: Beyond the inverted U. Trends Pharmacol Sci 24: 493-499.
89. Picciotto M.R., Zoli M, Rimondini R, Lena C, Marubio LM, Pich E.M., Fuxe K, Changeux JP. 1998. Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine. Nature 391: 173-177.
90. Pidoplichko V.I., Noguchi J, Areola OO, Liang Y, Peterson J, Zhang T., Dani JA. 2004. Nicotinic cholinergic synaptic mechanisms in the ventral tegmental area contribute to nicotine addiction. Learn Mem 11: 60-69.
91. Piper M.E., Cook JW, Schlam TR, Jorenby DE, Baker TB. 2011. Anxiety diagnoses in smokers seeking cessation treatment: Relations with tobacco dependence, withdrawal, outcome and response to treatment. Addiction 106: 418-427.
92. Pons S., Fattore L, Cossu G, Tolu S, Porcu E, McIntosh JM, Changeux J.P., MaskosU, FrattaW. 2008. Crucial role of α4 and α6 nicotinic acetylcholine receptor subunits from ventral tegmental area in systemic nicotine self-administration. J Neurosci 28: 12318-12327.
93. Pontieri F.E., Tanda G, Orzi F, Di Chiara G. 1996. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 382: 255-257.
94. Rice M.E., Cragg SJ. 2004. Nicotine amplifies reward-related dopamine signals in striatum. Nat Neurosci 7: 583-584.
95. Saccone S.F., Hinrichs AL, Saccone NL, Chase GA, Konvicka K., Madden PA, Breslau N, Johnson EO, Hatsukami D., Pomerleau O, et al. 2007. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet 16: 36-49.
96. Salas R., Orr-Urtreger A, Broide RS, Beaudet A, Paylor R, De Biasi M. 2003. The nicotinic acetylcholine receptor subunit α5 mediates short-term effects of nicotine in vivo. Mol Pharmacol 63: 1059-1066.
97. Salas R., Pieri F, De Biasi M. 2004. Decreased signs of nicotine withdrawal in mice null for the β4 nicotinic acetylcholine receptor subunit. J Neurosci 24: 10035-10039.
98. Salas R., Main A, Gangitano D, De Biasi M. 2007. Decreased withdrawal symptoms but normal tolerance to nicotine in mice null for the α7 nicotinic acetylcholine receptor subunit. Neuropharmacology 53: 863-869.
99. Salas R., Sturm R, Boulter J, De Biasi M. 2009. Nicotinic receptors in the habenulo-interpeduncular system are necessary for nicotine withdrawal in mice. J Neurosci 29: 3014-3018.
100. Schultz W. 1998a. The phasic reward signal of primate dopamine neurons. Adv Pharmacol 42: 686-690.
101. Schultz W. 1998b. Predictive reward signal of dopamine neurons. J Neurophysiol 80: 1-27.
102. SchultzW. 2007a. Behavioral dopamine signals. TrendsNeurosci 30: 203-210.
103. SchultzW. 2007b. Multiple dopamine functions at different time courses. Annu Rev Neurosci 30: 259-288.
104. Schultz W. 2010. Dopamine signals for reward value and risk: Basic and recent data. Behav Brain Funct 6: 24.
105. Sesack S.R., Grace AA. 2010. Cortico-basal ganglia reward network: Microcircuitry. Neuropsychopharmacology 35: 27-47.
106. Shen RY. 2003. Ethanol withdrawal reduces the number of spontaneously active ventral tegmental area dopamine neurons in conscious animals. J Pharmacol Exp Ther 307: 566-572.
107. Shiffman S. 2006. Reflections on smoking relapse research. Drug Alcohol Rev 25: 15-20.
108. Shiffman S., Gwaltney CJ, Balabanis MH, Liu KS, Paty JA, Kassel J.D., Hickcox M, Gnys M. 2002. Immediate antecedents of cigarette smoking: An analysis from ecological momentary assessment. J Abnorm Psychol 111: 531-545.
109. Sutherland R.J., Nakajima S. 1981. Self-stimulation of the habenular complex in the rat. J Comp Physiol Psychol 95: 781-791.
110. Tapper A.R., McKinney SL, Nashmi R, Schwarz J, Deshpande P., Labarca C, Whiteaker P, Marks MJ, Collins A.C., Lester HA. 2004. Nicotine activation of α4* receptors: Sufficient for reward, tolerance, and sensitization. Science 306: 1029-1032.
111. Thorgeirsson T.E., Geller F, Sulem P, Rafnar T, Wiste A, Magnusson K.P., Manolescu A, Thorleifsson G, Stefansson H., Ingason A, et al. 2008. Avariant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452: 638-642.
112. Ullsperger M., von Cramon DY. 2003. Error monitoring using external feedback: Specific roles of the habenular complex, the reward system, and the cingulate motor area revealed by functional magnetic resonance imaging. J Neurosci 23: 4308-4314.
113. Ungless M.A., Magill PJ, Bolam JP. 2004. Uniform inhibition of dopamine neurons in the ventral tegmental area by aversive stimuli. Science 303: 2040-2042.
114. Usuda I., Tanaka K, Chiba T. 1998. Efferent projections of the nucleus accumbens in the rat with special reference to subdivision of the nucleus: Biotinylated dextran amine study. Brain Res 797: 73-93.
115. Wallace D.M., Magnuson DJ, Gray TS. 1989. The amygdalobrainstem pathway: Selective innervation of dopaminergic, noradrenergic and adrenergic cells in the rat. Neurosci Lett 97: 252-258.
116. Wallace D.M., Magnuson DJ, Gray TS. 1992. Organization of amygdaloid projections to brainstem dopaminergic, noradrenergic, and adrenergic cell groups in the rat. Brain Res Bull 28: 447-454.
117. Wang J.C., Grucza R, Cruchaga C, Hinrichs AL, Bertelsen S, Budde J.P., Fox L, Goldstein E, Reyes O, Saccone N, et al. Genetic variation in the CHRNA5 gene affects mRNA levels and is associated with risk for alcohol dependence. Molec Psychiatry 14: 501-510.
118. Ward K.D., Klesges RC, Zbikowski SM, Bliss RE, Garvey AJ. 1997. Gender differences in the outcome of an unaided smoking cessation attempt. Addict Behav 22: 521-533.
119. Weiss F., Parsons LH, Schulteis G, Hyytia P, Lorang MT, Bloom F.E., Koob GF. 1996. Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependent rats. J Neurosci 16: 3474-3485.
120. West R.J., Hajek P, Belcher M. 1989. Severity of withdrawal symptoms as a predictor of outcome of an attempt to quit smoking. Psychol Med 19: 981-985.
121. WHO. 1997. Tobacco or health, a global status report, p. 495. World Health Organization, Geneva.
122. Wilson CJ. 2004. Basal ganglia. In The synaptic organization of the brain (ed. Shepherd GM), pp. 361-413. Oxford University Press, Oxford.
123. Winter C., Vollmayr B, Djodari-Irani A, Klein J, Sartorius A. 2011. Pharmacological inhibition of the lateral habenula improves depressive-like behavior in an animal model of treatment resistant depression. Behav Brain Res 216: 463-465.
124. Wise RA. 2009. Roles for nigrostriatal-not just mesocorticolimbic-dopamine in reward and addiction. Trends Neurosci 32: 517-524.
125. Wooltorton J.R., Pidoplichko VI, Broide RS, Dani JA. 2003. Differential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas. J Neurosci 23: 3176-3185.
126. Wu Q., Reith ME, Walker QD, Kuhn CM, Carroll FI, Garris PA. 2002. Concurrent autoreceptor-mediated control of dopamine release and uptake during neurotransmission: An in vivo voltammetric study. J Neurosci 22: 6272-6281.
127. Zachek M.K., Takmakov P, Park J, Wightman RM, McCarty GS. 2010. Simultaneous monitoring of dopamine concentration at spatially different brain locations in vivo. Biosens Bioelectron 25: 1179-1185.
128. Zahm DS. 2000. An integrative neuroanatomical perspective on some subcortical substrates of adaptive responding with emphasis on the nucleus accumbens. Neurosci Biobehav Rev 24: 85-105.
129. Zhang H., SulzerD. 2004. Frequency-dependent modulation of dopamine release by nicotine. Nat Neurosci 7: 581-582.
130. Zhang L., Zhou FM, Dani JA. 2004. Cholinergic drugs for Alzheimer's disease enhance in vitro dopamine release. Mol Pharmacol 66: 538-544.
131. Zhang L., Doyon WM, Clark JJ, Phillips PE, Dani JA. 2009a. Controls of tonic and phasic dopamine transmission in the dorsal and ventral striatum. Mol Pharmacol 76: 396-404.
132. Zhang T., Zhang L, Liang Y, Siapas AG, Zhou FM, Dani JA. 2009b. Dopamine signaling differences in the nucleus accumbens and dorsal striatum exploited by nicotine. J Neurosci 29: 4035-4043.
133. Zhang L., Dong Y, Doyon WM, Dani JA. 2012. Withdrawal from chronic nicotine exposure alters dopamine signaling dynamics in the nucleus accumbens. Biol Psychiatry 71: 184-191.
134. Zhao-Shea R, Liu L, Soll LG, Improgo MR, Meyers EE, McIntosh JM, Grady SR, Marks MJ, Gardner PD, Tapper AR. 2011. Nicotine-mediated activation of dopaminergic neurons in distinct regions of the ventral tegmental area. Neuropsychopharmacology 36: 1021-1032.
135. Zhou F.M., Liang Y, Dani JA. 2001. Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum. Nat Neurosci 4: 1224-1229.
136. Zhou F.M., Wilson CJ, Dani JA. 2002. Cholinergic interneuron characteristics and nicotinic properties in the striatum. J Neurobiol 53: 590-605.